Trinity Biotech (TRIB) Stock Price
Trinity Biotech Price
Revenue at Trinity Biotech has contracted by 5.1% per year over the past 19 years to 43.79 M USD. Earnings per share have grown at 25.2% per year over the last 15 years. For Trinity Biotech, the net margin of -85.4% is down versus 1.1% a few years ago. At today's price the dividend yield works out to roughly 615.49%. The consensus 12-month price target for Trinity Biotech is 4.08 USD, about 23.9% below where the stock trades today. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus.
Trinity Biotech stock price
Trinity Biotech business model & stock analysis
Frequently asked questions about Trinity Biotech
Analysts currently set an average price target of 4.08 USD for the Trinity Biotech stock (median: 4.08 USD), implying -23.9 % versus the latest price. The consensus is based on 7 analyst ratings.
7 analysts currently rate the Trinity Biotech stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Trinity Biotech to generate revenue of 59.50 M USD and earnings per share of -1.03 USD.
Converted at the current exchange rate, the Trinity Biotech share trades at 4.77 EUR (5.36 USD).
The Trinity Biotech share (TRIB) is listed on 4 stock exchanges, including: NASDAQ (TRIB), Frankfurt (TRBA.F), München (TRBA.MU), Düsseldorf (TRBA.DU).
The expected revenue of Trinity Biotech is 59.50 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Trinity Biotech is -385.00 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Trinity Biotech is currently -5.21. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Trinity Biotech stock.
The price-to-sales ratio (P/S) of Trinity Biotech is currently 33.72. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Trinity Biotech stock.
The Eulerpool Quality Score for Trinity Biotech is 1/10.
The ISIN of Trinity Biotech is US8964385046. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Trinity Biotech is A0ET3S. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Trinity Biotech is TRIB. The ticker symbol is used to trade Trinity Biotech shares on the stock exchange.
Trinity Biotech stock
Trinity Biotech Peer Group
Trinity Biotech Ticker
All fundamentals and in-depth analysis of Trinity Biotech
Our stock analysis for Trinity Biotech stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Trinity Biotech. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.